Загрузка...
Therapeutic gene editing in CD34(+) hematopoietic progenitors from Fanconi anemia patients
Gene targeting constitutes a new step in the development of gene therapy for inherited diseases. Although previous studies have shown the feasibility of editing fibroblasts from Fanconi anemia (FA) patients, here we aimed at conducting therapeutic gene editing in clinically relevant cells, such as h...
Сохранить в:
| Опубликовано в: : | EMBO Mol Med |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5666315/ https://ncbi.nlm.nih.gov/pubmed/28899930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201707540 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|